Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from EZZ Life Science Holdings Ltd. ( (AU:EZZ) ).
EZZ Life Science Holdings Limited announced the results of its Annual General Meeting, where the re-election of Mr. Glenn Cross as a director was withdrawn following his decision not to stand for re-election. The board expressed gratitude for his contributions, and CEO Mark Qin will serve as interim Chair. The announcement reflects ongoing leadership changes and strategic adjustments within the company, potentially impacting its governance and operational strategies.
The most recent analyst rating on (AU:EZZ) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is a life science company focused on enhancing quality of life and human health. The company invests in consumer health through e-commerce and distribution of high-quality products via omnichannel models across Australia, New Zealand, China, and globally. EZZ is also expanding its market presence into the United States, a significant growth market.
Average Trading Volume: 75,840
Technical Sentiment Signal: Buy
Current Market Cap: A$109M
See more data about EZZ stock on TipRanks’ Stock Analysis page.